Osteoarthritis Trial, Recruiting NCT06653985 Sponsor: ArthroBiologix Inc. Condition: Osteoarthritis
Back to Osteoarthritis

Osteoarthritis Trial, Recruiting

NCT06653985
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are between 40 and 60 years old
  • You have been diagnosed with mild hip arthritis (early stage), and you may also have a torn hip labrum, a hip bone shape problem (femoroacetabular impingement), or mild hip socket shallowness (mild dysplasia)
  • After receiving a guided anaesthetic injection into your hip joint, your hip pain reduced by more than half
  • You are able to pay for private physiotherapy sessions yourself
  • You are able to give your informed consent to take part in the study

Who may not be able to join:

  • You currently have an active infection anywhere in your body
  • You have bone death in the hip (osteonecrosis), moderate to severe hip arthritis, or moderate to severe hip socket shallowness (dysplasia)
  • You have had a previous fracture of the hip, pelvis, or any bone in your lower limb
  • You have had previous surgery on your pelvis, hip, or lower limb
  • You have a condition that causes very flexible or fragile joints or connective tissue (such as Ehlers-Danlos syndrome or Marfan's syndrome)
  • You have ongoing chronic lower back pain and/or sciatica
  • You have received a steroid injection into your hip joint within the last 3 months
  • You have previously received a hyaluronic acid injection into your hip
  • Your hip injury was caused by a car accident
  • Your hip injury happened at work and you have a workers' compensation claim
  • Your injury is involved in any legal dispute
  • You are pregnant or planning to become pregnant
  • You are already taking part in another study that does not allow you to join additional studies
  • You are unable to give informed consent
  • You are unable to follow the study plan and requirements
  • You have a medical reason why you cannot receive a steroid or hyaluronic acid injection (confirm with trial site)
  • You have previously taken part in this same study

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: (289) 389-8181

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
ArthroBiologix Inc.
Registry
ClinicalTrials.gov
Start date
1 May 2024
Est. completion
31 October 2026

Where this trial is recruiting

🇨🇦 Canada

Primary endpoints

Numeric Pain Rating Scale (NPRS)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov